Restricted accessResearch articleFirst published online 2010-10
Subfractionation of Differentiating Human Embryonic Stem Cell Populations Allows the Isolation of a Mesodermal Population Enriched for Intermediate Mesoderm and Putative Renal Progenitors
Human embryonic stem (ES) cells are pluripotent and are believed to be able to generate all cell types in the body. As such, they have potential applications in regenerative therapy for kidney disease. However, before this can be achieved, a protocol to differentiate human ES cells to mesodermal renal progenitor lineages is required. Reduction of serum concentration and feeder layer density reduction cultures were used to differentiate human ES cells for 14 days. Differentiated ES cells were then fractionated by flow cytometry based on expression of the markers CD24, podocalyxin, and GCTM2 to isolate putative renal cells. These cells up-regulated the expression of the renal transcription factors PAX2, LHX1, and WT1 when compared with unfractionated human ES cells. Immunohistochemical assays confirmed that a subset of cells within this fraction co-expressed nuclear WT1 and PAX2 proteins. Transcriptome profiling also showed that the most differentially up-regulated genes in this fraction preferentially associated with kidney development in comparison with any other lineage. When compared with a transcriptome profile database of urogenital development (GUDMAP), the top 200 differentially up-regulated genes in this fraction strongly clustered into a group of genes associated with the metanephric mesenchyme at E11.5 and the corticonephrogenic interstitium at E15.5 of murine kidney development. Hence, this approach confirms an ability to direct human ES cells toward a renal progenitor state.
Get full access to this article
View all access options for this article.
References
1.
ErcegS, LaínezS, RonaghiM, StojkovicP, Pérez-AragóMA, Moreno-ManzanoV, Moreno-PalanquesR, Planells-CasesR, StojkovicM. 2008. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS ONE, 3:e2122.
2.
CohenMA, ItsyksonP, ReubinoffBE. 2007. Neural differentiation of human ES cells. Curr Protoc Cell Biol, 36:23.7.1–23.7.20.
3.
FerreiraLS, GerechtS, ShiehHF, WatsonN, RupnickMA, DallabridaSM, Vunjak-NovakovicG, LangerR. 2007. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res, 101:286–294.
4.
NakagamiH, NakagawaN, TakeyaY, KashiwagiK, IshidaC, HayashiS, AokiM, MatsumotoK, NakamuraT, OgiharaT, MorishitaR. 2006. Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine. Hypertension, 48:112–119.
5.
KarnerE, BäckesjöCM, CedervallJ, SugarsRV, Ahrlund-RichterL, WendelM. 2009. Dynamics of gene expression during bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Biochim Biophys Acta, 1790:110–118.
6.
KärnerE, LingerC, SloanAJ, Ahrlund-RichterL, SugarsRV, WendelM. 2007. Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev, 16:39–52.
7.
LeeKW, YookJY, SonMY, KimMJ, KooDB, HanYM, ChoYS. 2009. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev, 19:557–568.
TranTH, WangX, BrowneC, ZhangY, SchinkeM, IzumoS, BurcinM. 2009. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells, 27:1869–1878.
10.
BorowiakM, MaehrR, ChenS, ChenAE, TangW, FoxJL, SchreiberSL, MeltonDA. 2009. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell, 4:348–358.
11.
Van HoofD, D'AmourKA, GermanMS. 2009. Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Res, 3:73–87.
12.
SasakiK, IchikawaH, TakeiS, NoHS, TomotsuneD, KanoY, YokoyamaT, SirasawaS, MogiA, YoshieS, SasakiS, YamadaS, MatsumotoK, MizuguchiM, YueF, TanakaY. 2009. Hepatocyte differentiation from human ES cells using the simple embryoid body formation method and the staged-additional cocktail. Scientific World Journal, 9:884–890.
13.
SynnergrenJ, HeinsN, BrolenG, ErikssonG, LindahlA, HyllnerJ, OlssonB, SartipyP, BjorquistP. 2009. Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further towards the hepatic lineage. Stem Cells Dev.
14.
JiL, Allen-HoffmannBL, de PabloJJ, PalecekSP. 2006. Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors. Tissue Eng, 12:665–679.
15.
MetalloCM, JiL, de PabloJJ, PalecekSP. 2008. Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells, 26:372–380.
16.
ClarkAT, BodnarMS, FoxM, RodriquezRT, AbeytaMJ, FirpoMT, PeraRA. 2004. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet, 13:727–739.
17.
ParkTS, GalicZ, ConwayAE, LindgrenA, van HandelBJ, MagnussonM, RichterL, TeitellMA, MikkolaHK, LowryWE, PlathK, ClarkAT. 2009. Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells. Stem Cells, 27:783–795.
XuRH. 2006. In vitro induction of trophoblast from human embryonic stem cells. Methods Mol Med, 121:189–202.
20.
SteenhardBM, IsomKS, CazcarroP, DunmoreJH, GodwinAR, St JohnPL, AbrahamsonDR. 2005. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol, 16:1623–1631.
21.
KimD, DresslerGR. 2005. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol, 16:3527–3534.
22.
VigneauC, PolgarK, StrikerG, ElliottJ, HyinkD, WeberO, FehlingHJ, KellerG, BurrowC, WilsonP. 2007. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol, 18:1709–1720.
23.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, JonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
24.
ReubinoffBE, PeraMF, FongCY, TrounsonA, BongsoA. 2000. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat B iotechnol, 18:399–404.
25.
GertowK, WolbankS, RozellB, SugarsR, AndängM, ParishCL, ImrehMP, WendelM, Ahrlund-RichterL. 2004. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev, 13:421–435.
26.
SchuldinerM, YanukaO, Itskovitz-EldorJ, MeltonDA, BenvenistyN. 2000. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA, 97:11307–11312.
27.
BatchelderCA, LeeCC, MatsellDG, YoderMC, TarantalAF. 2009. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation, 78:45–56.
28.
SaxenL. 1987. Organogenesis of the Kidney. Cambridge University Press: Cambridge.
29.
RumballeB, GeorgasK, WilkinsonL, LittleM. 2010. Molecular anatomy of the kidney: what have we learned from gene expression and functional genomics?Pediatr Nephrol, 25:1005–1016.
30.
ChallenGA, MartinezG, DavisMJ, TaylorDF, CroweM, TeasdaleRD, GrimmondSM, LittleMH. 2004. Identifying the molecular phenotype of renal progenitor cells. J Am Soc Nephrol, 15:2344–2357.
PeraMF, FilipczykAA, HawesSM, LaslettAL. 2003. Isolation, characterization, and differentiation of human embryonic stem cells. Meth Enzymol, 365:429–446.
39.
HerszfeldD, WolvetangE, Langton-BunkerE, ChungTL, FilipczykAA, HoussamiS, JamshidiP, KohK, LaslettAL, MichalskaA, NguyenL, ReubinoffBE, TellisI, AuerbachJM, OrdingCJ, LooijengaLH, PeraMF. 2006. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol, 24:351–357.
40.
WertzK, HerrmannBG. 1999. Kidney-specific cadherin (cdh16) is expressed in embryonic kidney, lung, and sex ducts. Mech Dev, 84:185–188.
41.
LaslettAL, GrimmondS, GardinerB, StampL, LinA, HawesSM, WormaldS, Nikolic-PatersonD, HaylockD, PeraMF. 2007. Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev Biol, 7:12.
42.
KolleG, HoM, ZhouQ, ChyHS, KrishnanK, CloonanN, BertoncelloI, LaslettAL, GrimmondSM. 2009. Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling. Stem Cells, 27:2446–2456.
43.
SchopperleWM, KershawDB, DeWolfWC. 2003. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun, 300:285–290.
44.
BrunskillEW, AronowBJ, GeorgasK, RumballeB, ValeriusMT, AronowJ, KaimalV, JeggaAG, YuJ, GrimmondS, McMahonAP, PattersonLT, LittleMH, PotterSS. 2008. Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell, 15:781–791.
45.
McLeanAB, D'AmourKA, JonesKL, KrishnamoorthyM, KulikMJ, ReynoldsDM, SheppardAM, LiuH, XuY, BaetgeEE, DaltonS. 2007. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells, 25:29–38.
46.
PhillipsBW, HentzeH, RustWL, ChenQP, ChipperfieldH, TanEK, AbrahamS, SadasivamA, SoongPL, WangST, LimR, SunW, ColmanA, DunnNR. 2007. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev, 16:561–578.
47.
TropepeV, HitoshiS, SirardC, MakTW, RossantJ, van der KooyD. 2001. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron, 30:65–78.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
